Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis

Author(s): Lifang Wang, Yu Zhang, Mingqin Zhu, Jiachun Feng*, Jinming Han, Jie Zhu, Hui Deng*.

Journal Name: Current Molecular Medicine

Volume 19 , Issue 10 , 2019

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Abstract:

Background: Myasthenia gravis (MG) is an autoimmune disorder mediated by antibodies against the acetylcholine receptors (AChR) of the skeletal muscles. An imbalance in various T helper (Th) cells, including Th1, Th2, Th17, Th22 and follicular helper T (TFH) cells, has been found associated with immunological disturbances.

Objective: In this study, we aim to investigate the role of the Th cells in peripheral blood of MG patients.

Materials and Methods: A total of 33 MG patients and 34 age matched controls were enrolled in this study. Peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll-Paque density gradient centrifugation assay. The proportion of TFH cells in PBMC were analyzed using flow-cytometry assay by determining the levels of cellular markers CD4, CXCR5, CD45RO, CD45RA and ICOS and PD-1. The levels of IFN-γ, IL-4, IL-17 and IL-21 in serum were analyzed by Cytometric Bead Array. The serum IL-22 level was analyzed by ELISA.

Results: The frequency of TFH cells in PBMCs was higher than those in healthy subjects and correlated to the severity of MG patients. The levels of pro-inflammatory cytokines IFN-γ, IL-17 and IL-21 were elevated in the serum of MG patients, while there were no significant differences regarding the levels of IL-4 and IL-22 between MG patients and control subjects.

Conclusion: Our findings suggest that Th cells and their cytokines balance of MG patients are involved in the clinical condition or severity of MG disease.

Keywords: Myasthenia gravis, follicular helper T cells, T helper cells, quantitative myasthenia gravis score, IFN-γ, IL-17.

[1]
Mcheyzer-Williams LJ, Mcheyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005; 23: 487-513.
[2]
Toellner KM, Luther SA, Sze DM, et al. T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 1998; 187(8): 1193-204.
[3]
Patel DD, Kuchroo VK. Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions. Immunity 2015; 43(6): 1040-51.
[4]
Xu Y, Zhu Q, Song J, et al. Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis. Mediators Inflamm 2015; 2015356040
[5]
Li S, Jin T, Zhang HL, et al. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg treatments. Mediators Inflamm 2014; 2014740947
[6]
Azizi G, Simhag A. M-M-El Rouby N, et al Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases. Iran J Allergy Asthma Immunol 2015; 14(3): 246-54.
[7]
Schaerli P, Willimann K, Lang A, et al. Cxc chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000; 192(11): 1553-62.
[8]
Laurent C, Fazilleau N, Brousset P. A novel subset of T-helper cells: follicular T-helper cells and their markers. Haematologica 2010; 95(3): 356-8.
[9]
Simpson N, Gatenby PA, Wilson A, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 2010; 62(1): 234-44.
[10]
Zhu C, Ma J, Liu Y, et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2012; 97(3): 943-50.
[11]
Dai H, Sun T, Liu Z, et al. The imbalance between regulatory and IL-17-secreting CD4(+)T cells in multiple-trauma rat. Injury 2013; 44(11): 1521-7.
[12]
Wu H, Wang K, Li G, et al. Effects of transcutaneous acupoint electrical stimulation on the imbalance of Th1, Th2, Th17and Treg cells following thoracotomy of patients with lung cancer. Exp Ther Med 2016; 11(2): 495-502.
[13]
Luo C, Li Y, Liu W, et al. Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis. J Neuroimmunol 2013; 256(1-2): 55-61.
[14]
Schaffert H, Pelz A, Saxena A, et al. IL-17-producing CD4 T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis. Eur J Immunol 2015.
[15]
Bossaller L, Burger J, Draeger R, et al. ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J Immunol 2006; 177(7): 4927-32.
[16]
Good-Jacobson KL, Szumilas CG, Chen L, et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol 2010; 11(6): 535-42.
[17]
Nurieva RI, Chung Y, Hwang D, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008; 29(1): 138-49.
[18]
Ettinger R, Sims GP, Fairhurst AM, et al. IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells. The Journal of Immunology, 2005; 175(12): 7867-79.
[19]
Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annual Review of Immunology 1994; 12(1): 85.
[20]
Kung C, Pingel JT, Heikinheimo M, et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000; 6(3): 343-5.
[21]
Huang S, Wang W, Chi L. Feasibility of up-regulating CD4+CD25+ Tregs by IFN-γ in myasthenia gravis patients. BMC Neurol 2015; 15(1): 1-10.
[22]
Curtis JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 2006; 55(3): 420-6.
[23]
Bai Y, Liu R, Huang D, et al. CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity. Eur J Immunol 2008; 38: 1877-88.
[24]
Cheng F, Guo Z, Xu H, et al. Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2009; 68(4): 604-6.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 10
Year: 2019
Page: [739 - 745]
Pages: 7
DOI: 10.2174/1566524019666190827162615
Price: $65

Article Metrics

PDF: 34
HTML: 2